Company intelligence / Profile preview

Mercury Capital Management

Sydney, New South Wales, Australiamercurycm.org ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Mercury Capital Management refers to several entities: 1. A student-run investment fund at the University of St Andrews focused on small-cap equities and alternative investments including biotechnology and pharmaceuticals but not itself a biotech/pharma/CRO company. 2. An established private equity firm based in Sydney ("Mercury Capital") investing heavily in healthcare services and life science service providers such as Novotech (a leading Asia-Pacific CRO) and Tamaki Health (primary care clinics).

Industry: Investors

Partnerships

Portfolio includes partnerships via investments

Beyond the preview

Go deeper on Mercury Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mercury Capital Management.

Explore the full profile